Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith C Ferdinand

Showing results (201-210 of 287) with videos related to

Pageof 29
Sort By:
Journal of Cardiovascular Pharmacology and Therapeutics|March 6, 2012
Vascular effects of nebivolol added to hydrochlorothiazide in African Americans with hypertension and echocardiographic evidence of diastolic dysfunction: the NASAA studyBobby V Khan, Syed T Rahman, Tahir Haque, et al.
Mayo Clinic Proceedings|January 5, 2008
Improved attainment of blood pressure and cholesterol goals using single-pill amlodipine/atorvastatin in African Americans: the CAPABLE trialJohn M Flack, Ronald Victor, Karol Watson, et al.
Advances in Therapy|March 6, 2023
Real-World Racial Variation in Treatment and Outcomes Among Patients with Peripheral Artery DiseaseKeith C Ferdinand, Kay Sadik, Richard Browne, et al.
American Heart Journal|July 12, 2011
Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trialMichelle A Albert, Robert J Glynn, Francisco A H Fonseca, et al.
Hypertension (Dallas, Tex. : 1979)|November 17, 2021
Self-Reported Antihypertensive Medication Class and Temporal Relationship to Treatment GuidelinesBrent M Egan, Jianing Yang, Michael K Rakotz, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 20, 2006
Antihypertensive efficacy of Irbesartan/HCTZ in men and women with the metabolic syndrome and type 2 diabetesJames R Sowers, Joel M Neutel, Elijah Saunders, et al.
Journal of the American College of Cardiology|January 28, 2017
Improving Medication Adherence in Cardiometabolic Disease: Practical and Regulatory ImplicationsKeith C Ferdinand, Fortunato Fred Senatore, Helene Clayton-Jeter, et al.
Journal of the National Medical Association|April 21, 2006
Irbesartan/HCTZ fixed combinations in patients of different racial/ethnic groups with uncontrolled systolic blood pressure on monotherapyElizabeth O Ofili, Keith C Ferdinand, Elijah Saunders, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 18, 2005
The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trialJoel M Neutel, Elijah Saunders, George L Bakris, et al.
Ethnicity & Disease|June 7, 2024
Barriers and Facilitators to Improving Cardiovascular Health in Churches with Predominantly Black CongregationsAna Peralta-Garcia, Jodie Laurent, Alessandra N Bazzano, et al.
Pageof 29

Showing results (201-210 of 287) with videos related to

Sort By:
Pageof 29
Journal of Cardiovascular Pharmacology and Therapeutics|March 6, 2012
Vascular effects of nebivolol added to hydrochlorothiazide in African Americans with hypertension and echocardiographic evidence of diastolic dysfunction: the NASAA studyBobby V Khan, Syed T Rahman, Tahir Haque, et al.
Mayo Clinic Proceedings|January 5, 2008
Improved attainment of blood pressure and cholesterol goals using single-pill amlodipine/atorvastatin in African Americans: the CAPABLE trialJohn M Flack, Ronald Victor, Karol Watson, et al.
Advances in Therapy|March 6, 2023
Real-World Racial Variation in Treatment and Outcomes Among Patients with Peripheral Artery DiseaseKeith C Ferdinand, Kay Sadik, Richard Browne, et al.
American Heart Journal|July 12, 2011
Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trialMichelle A Albert, Robert J Glynn, Francisco A H Fonseca, et al.
Hypertension (Dallas, Tex. : 1979)|November 17, 2021
Self-Reported Antihypertensive Medication Class and Temporal Relationship to Treatment GuidelinesBrent M Egan, Jianing Yang, Michael K Rakotz, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 20, 2006
Antihypertensive efficacy of Irbesartan/HCTZ in men and women with the metabolic syndrome and type 2 diabetesJames R Sowers, Joel M Neutel, Elijah Saunders, et al.
Journal of the American College of Cardiology|January 28, 2017
Improving Medication Adherence in Cardiometabolic Disease: Practical and Regulatory ImplicationsKeith C Ferdinand, Fortunato Fred Senatore, Helene Clayton-Jeter, et al.
Journal of the National Medical Association|April 21, 2006
Irbesartan/HCTZ fixed combinations in patients of different racial/ethnic groups with uncontrolled systolic blood pressure on monotherapyElizabeth O Ofili, Keith C Ferdinand, Elijah Saunders, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 18, 2005
The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trialJoel M Neutel, Elijah Saunders, George L Bakris, et al.
Ethnicity & Disease|June 7, 2024
Barriers and Facilitators to Improving Cardiovascular Health in Churches with Predominantly Black CongregationsAna Peralta-Garcia, Jodie Laurent, Alessandra N Bazzano, et al.
Pageof 29